Unknown

Dataset Information

CD137 stimulation enhances the vaccinal effect of anti-tumor antibodies.


ABSTRACT: Some evidence suggests that monoclonal antibodies (mAb) can induce an adaptive immune response against tumor cells ("vaccinal effect"). Recently, we have shown that an anti-CD137 mAb can enhance the "vaccinal effect" of an anti-tumor mAb (cetuximab), thereby transforming a passive, monoclonal, short-term immunotherapy into an active, polyclonal, long-lasting immune response.

SUBMITTER: Houot R 

PROVIDER: S-EPMC4292240 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature